Uncovering Molecular Mechanisms for Treatment of Congenital Heart Defects Through High-Content Genetic Perturbation Screens
ISEF · 2025 Biomedical and Health Sciences
Overview
Congenital heart defects (CHDs) refer to structural defects in the heart that are present at birth. Hypoplastic Left Heart Syndrome (HLHS) is the most complex CHD and occurs when the left side of the heart is underdeveloped. It is responsible for 40% of neonatal cardiac deaths and, even with surgical interventions, reduces life expectancy by ~50 years. The underlying causes of HLHS are largely unknown, limiting development of targeted therapies. This study aims to uncover the molecular mechanisms of HLHS using genetic perturbations. Cardiomyocytes were differentiated from human induced pluripotent stem cells (hiPSCs) of both a patient affected by HLHS and his healthy father as a control. siRNA knockdowns systematically silenced 115 genes, with a distinct loss-of-function perturbation in each different cell. Immunostaining and high-content imaging quantified phenotypic changes, and a machine learning model was trained (86% accuracy) on control samples to classify perturbations as 'healthy' or 'unhealthy.' Additional analyses (Genome-Wide Association Studies, Principal Component Analysis, and feature correlation) identified key drivers of HLHS pathology. Genes that move patient cells toward a healthy-like state (PPP1R13B, RAI14, SIRT5) were identified as potential therapeutic targets with a 2.15-fold decrease in score (p < 0.05). Conversely, genes that drive father cells toward a patient-like phenotype (PBX1, NR6A1, PRDM16) were implicated in HLHS development with a 3.3-fold increase in score (p < 0.05). The acyl chain remodeling pathway was linked to these genetic changes, implying the role of lipid metabolism in disease development. These findings provide novel insights into HLHS pathogenesis and hold potential to improve diagnostic and therapeutic interventions.
Competition history
- ISEF 2025
Resources
Related projects
ISEF · 2020
Determining Gene Interactions in Congenital Heart Disease for Development of a Comprehensive Fetal Cardiac Diagnostics Platform
ISEF · 2022
Investigating Epigenetic Modifications in Chromosome Structure in Cardiomyocyte Differentiation Mechanisms for Heart Disease Treatment
ISEF · 2025
A CRISPR Knockout Screen Systematically Identifies Critical Epigenetic Barriers in Direct Cardiac Reprogramming
ISEF · 2018
3D Printing of Bioengineered Human Cardiac Stem Cells
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair